|
Re: U.S Election 2020
https://eu.detroitnews.com/story/new...ys/3595750001/
Quote:
President Donald Trump is in “good spirits” after his Covid-19 diagnosis on Friday and has been treated with a Regeneron Pharmaceuticals Inc. “antibody cocktail,” the White House physician said.
“Following PCR-confirmation of the president’s diagnosis, as a precautionary measure he received a single 8 gram dose of Regenerons’s polyclonal antibody cocktail,” the physician, Sean Conley, said in a statement released by White House Press Secretary Kayleigh McEnany.
|
They’ve given Trump an antibody cocktail that is currently in Stage 3 trials - that’s interesting...
https://www.regeneron.com/covid19
Quote:
|
REGN-COV2 is currently being studied in four late-stage clinical trials: two Phase 2/3 trials for the treatment of hospitalized and non-hospitalized (“ambulatory”) COVID-19 patients, the open-label, Phase 3 RECOVERY trial of hospitalized COVID-19 patients in the UK, and a Phase 3 trial for the prevention of COVID-19 in uninfected people who are at high-risk of exposure to a COVID-19 patient (such as the patient’s housemate).
|
Regeneron press release from 3 days ago
https://newsroom.regeneron.com/news-...ral-levels-and
Quote:
Additional Trial Background
Among the first 275 patients, approximately 56% were Hispanic, 13% were African American and 64% had one or more underlying risk factors for severe COVID-19, including obesity (more than 40%). On average, patients were 44 years of age. In total, 49% of participants were male and 51% were female.
At least 1,300 patients will be recruited into the Phase 2/3 portion of the outpatient trial overall. Patients will be followed for 29 days, with viral shedding in the upper respiratory tract assessed approximately every 2-3 days in the Phase 2 portion of the trial and clinical endpoints assessed via investigator and patient-reported data throughout.
In addition to this trial in non-hospitalized patients, REGN-COV2 is currently being studied in a Phase 2/3 clinical trial for the treatment of COVID-19 in hospitalized patients, the Phase 3 open-label RECOVERY trial of hospitalized patients in the UK and a Phase 3 trial for the prevention of COVID-19 in household contacts of infected individuals. Recruitment in all 4 trials is ongoing.
|
Giving the President a treatment that’s only been tested on less than 2000 people is concerning, imho.
Just on the news = Trump on way to Walter Reed Medical Center (by helicopter).
__________________
Thank you for calling the Abyss.
If you have called to scream, please press 1 to be transferred to the Void, or press 2 to begin your stare.
If my post is in bold and this colour, it's a Moderator Request.
Last edited by Hugh; 02-10-2020 at 22:24.
|